Items where authors include "Pease, CT"

Export as [feed] Atom [feed] RSS
Number of items: 15.

Article

Pepple, S, Arnold, J, Vital, EM orcid.org/0000-0003-1637-4755 et al. (5 more authors) (2022) Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome. ACR Open Rheumatology, 4 (8). pp. 689-699. ISSN 2578-5745

Tarn, JR, Howard-Tripp, N, Lendrem, DW et al. (48 more authors) (2019) Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials. The Lancet Rheumatology, 1 (2). e85-e94. ISSN 2665-9913

Fisher, BA, Everett, CC orcid.org/0000-0002-9788-840X, Rout, J et al. (24 more authors) (2018) Effect of rituximab on a salivary gland ultrasound score in primary Sjogren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy. Annals of the Rheumatic Diseases, 77 (3). pp. 412-416. ISSN 0003-4967

Oni, C, Mitchell, S, James, K et al. (31 more authors) (2017) Eligibility for clinical trials in primary Sjögren’s syndrome: lessons from the UK Primary Sjögren’s Syndrome Registry. Rheumatology, 56 (12). p. 2255. ISSN 1462-0324

Bezzina, OM, Gallagher, P, Mitchell, S et al. (30 more authors) (2017) Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the discrepancy. Arthritis Care and Research, 69 (11). pp. 1714-1723. ISSN 2151-464X

Bowman, SJ, Everett, CC orcid.org/0000-0002-9788-840X, O'Dwyer, JL orcid.org/0000-0002-7212-6089 et al. (21 more authors) (2017) Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome. Arthritis & Rheumatology, 69 (7). pp. 1440-1450. ISSN 2326-5191

Carmona, DF, Vaglio, A, Mackie, SL orcid.org/0000-0003-2483-5873 et al. (53 more authors) (2017) A genome-wide association study identifies risk alleles in plasminogen and P4HA2 associated with giant cell arteritis. American Journal of Human Genetics, 100 (1). pp. 64-74. ISSN 0002-9297

Howard Tripp, N, Tarn, J, Natasari, A et al. (29 more authors) (2016) Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines. RMD Open, 2 (2). e000282.

Helliwell, T, Brouwer, E, Pease, CT et al. (9 more authors) (2016) Development of a Provisional Core Domain Set for Polymyalgia Rheumatica: Report from the OMERACT 12 Polymyalgia Rheumatica Working Group. Journal of Rheumatology, 43 (1). pp. 182-186. ISSN 0315-162X

Mackie, SL orcid.org/0000-0003-2483-5873, Pease, CT, Fukuba, E et al. (5 more authors) (2015) Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids. Annals of the Rheumatic Diseases, 72 (12). pp. 2188-2192. ISSN 0003-4967

Mackie, SL, Taylor, JC, Haroon-Rashid, L et al. (12 more authors) (2015) Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation. Arthritis Research & Therapy, 17. 195. ISSN 1478-6354

Vital, EM orcid.org/0000-0003-1637-4755, Wittmann, M orcid.org/0000-0003-2328-4926, Edward, S et al. (5 more authors) (2015) Brief report: Responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus. Arthritis and Rheumatology, 67 (6). pp. 1586-1591. ISSN 2326-5191

David Carmona, F, Mackie, SL, Martin, J-E et al. (70 more authors) (2015) A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility. American Journal of Human Genetics, 96 (4). pp. 565-580. ISSN 0002-9297

Lendrem, D, Mitchell, S, McMeekin, P et al. (28 more authors) (2015) Do the EULAR Sjögren’s syndrome outcome measures correlate with health status in primary Sjögren’s syndrome? Rheumatology, 54 (4). pp. 655-659. ISSN 1462-0324

Proceedings Paper

Bowman, S, Everett, C, Bombardieri, M et al. (15 more authors) (2015) Preliminary Results of a Double-Blind Randomised Trial of Rituximab Anti-B-Cell Therapy in Patients with Primary Sjogrens Syndrome. In: Arthritis and Rheumatology. 2015 ACR/ARHP Annual Meeting, 06-11 Nov 2015, San Francisco, CA. Wiley .

This list was generated on Sun Apr 21 11:17:02 2024 BST.